Company Lepu Medical Technology (Beijing) Co., Ltd.
Equities
300003
CNE100000H44
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.65 CNY | -1.21% | -2.29% | -6.08% |
Nov. 27 | Lepu Biopharma Renews Procurement Contract with Controlling Shareholder | MT |
Oct. 25 | Lepu Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
Business description: Lepu Medical Technology (Beijing) Co., Ltd.
- sale of medical devices and instruments (46.1%): primarily for cardiovascular interventions, cardiac surgery, cardiac rhythm management, anesthesia, intensive care, in vitro diagnostics and general surgery;
- sale of active pharmaceutical ingredients (38.1%): for the manufacturing of pharmaceutical products in the fields of cardiovascular diseases, infectious diseases, oncology, central nervous system disorders, etc.;
- sale of digital health and hospital network management solutions (15.8%).
Sales by Activity: Lepu Medical Technology (Beijing) Co., Ltd.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Medical Instruments | 3.62B | 3.4B | 6.17B | 5.88B | 3.67B |
Medicines | 3.85B | 3.41B | 3.26B | 3.44B | 3.04B |
Medical Services and Health Management | - | 1.23B | 1.23B | 1.29B | 1.26B |
New Industries | 59.48M | - | - | - | - |
Medical Service | 265M | - | - | - | - |
Geographical breakdown of sales: Lepu Medical Technology (Beijing) Co., Ltd.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Foreign | 554M | 1.54B | 3.76B | 1.08B | - |
China | 7.24B | 6.5B | 6.9B | 9.53B | - |
Managers: Lepu Medical Technology (Beijing) Co., Ltd.
Director | Title | Age | Since |
---|---|---|---|
Fei Pu
CEO | Chief Executive Officer | 36 | 2024-09-23 |
Zhong Jie Pu
CEO | Chief Executive Officer | 62 | 2007-12-28 |
Wang Yong
DFI | Director of Finance/CFO | 52 | 2007-02-28 |
Jing Jing Li
IRC | Investor Relations Contact | - | - |
Wei Na Jiang
SEC | Corporate Secretary | 46 | 2021-07-13 |
Members of the board: Lepu Medical Technology (Beijing) Co., Ltd.
Manager | Title | Age | Since |
---|---|---|---|
Zhong Jie Pu
CHM | Chairman | 62 | 2007-12-28 |
Fei Pu
BRD | Director/Board Member | 36 | 2020-01-21 |
Liang Gan
BRD | Director/Board Member | 58 | 2020-01-21 |
Xing Lin Wang
CHM | Chairman | 63 | 2020-01-21 |
Jun Wang
BRD | Director/Board Member | 50 | 2020-01-21 |
Li Hua Wang
BRD | Director/Board Member | 63 | 2020-04-20 |
Yang Xu
BRD | Director/Board Member | 57 | 2013-12-31 |
Qi Hong Wang
BRD | Director/Board Member | 60 | 2021-03-24 |
Xin Qu
BRD | Director/Board Member | 62 | 2021-03-09 |
Qian Chen
BRD | Director/Board Member | 47 | 2013-12-26 |
Holdings: Lepu Medical Technology (Beijing) Co., Ltd.
Name | Equities | % | Valuation |
---|---|---|---|
280,000,000 | 80.75% | 627,914,000 $ | |
LEPU BIOPHARMA CO., LTD. 13.61% | 225,352,113 | 13.61% | 76,006,761 $ |
BIOLINERX LTD. 7.66% | 102,437,055 | 7.66% | 1,798,795 $ |
Company details: Lepu Medical Technology (Beijing) Co., Ltd.
Lepu Medical Technology (Beijing) Co., Ltd.
No. 37 Chaoqian Road Changping District
102200, Beijing
+86 10 8012 0666
http://www.lepumedical.comOther Medical Equipment, Supplies & Distribution
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-1.21% | -2.29% | -22.60% | -55.96% | 2.73B | ||
+1.54% | +6.81% | +3.92% | -4.16% | 203B | ||
-0.23% | +3.36% | +2.08% | -15.30% | 113B | ||
-0.45% | +2.93% | +1.49% | -7.91% | 69.71B | ||
+0.78% | +3.82% | +13.11% | +87.58% | 47.37B | ||
+1.20% | +6.12% | +17.01% | +41.73% | 47.31B | ||
+1.05% | +8.33% | -32.63% | -18.37% | 33.72B | ||
+3.05% | +1.10% | +19.64% | +41.51% | 27.85B | ||
+0.64% | +5.20% | -0.28% | -9.75% | 24.96B | ||
-0.21% | +3.51% | -10.07% | -10.84% | 22B | ||
Average | +0.62% | +3.24% | -0.83% | +4.85% | 59.15B | |
Weighted average by Cap. | +0.81% | +3.46% | +2.90% | +4.90% |
Sector
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300003 Stock
- Company Lepu Medical Technology (Beijing) Co., Ltd.